Octreoscan

Last updated on RxList: 5/28/2020
Octreoscan Side Effects Center

What Is Octreoscan?

Octreoscan (indium in -111 pentetreotide kit) is a diagnostic radiopharmaceutical used for the scintigraphic localization of primary and metastatic neuroendocrine tumors bearing somatostatin receptors.

What Are Side Effects of Octreoscan?

Side effects of Octreoscan include:

Dosage for Octreoscan

The recommended intravenous dose of Octreoscan for planar imaging is 111 MBq (3.0 mCi) of indium In-111 pentetreotide prepared from an Octreoscan kit. The recommended intravenous dose of Octreoscan for SPECT imaging is 222 MBq (6.0 mCi) of indium In-111 pentetreotide.

Octreoscan In Children

Safety and effectiveness of Octreoscan in pediatric patients have not been established.

What Drugs, Substances, or Supplements Interact with Octreoscan?

Octreoscan may interact with other medicines.

Tell your doctor all medications and supplements you use.

Octreoscan During Pregnancy and Breastfeeding

Tell your doctor if you are pregnant or plan to become pregnant before using Octreoscan; it is unknown if it would harm a fetus. It is unknown if Octreoscan passes into breast milk. Consult your doctor before breastfeeding.

Additional Information

Our Octreoscan (indium in -111 pentetreotide kit) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

SLIDESHOW

Skin Cancer Symptoms, Types, Images See Slideshow
Octreoscan Professional Information

SIDE EFFECTS

The following adverse effects were observed in clinical trials at a frequency of less than 1% of 538 patients: dizziness, fever, flush, headache, hypotension, changes in liver enzymes, joint pain, nausea, sweating, and weakness. These adverse effects were transient. Also in clinical trials, there was one reported case of bradycardia and one case of decreased hematocrit and hemoglobin.

Pentetreotide is derived from octreotide which is used as a therapeutic agent to control symptoms from certain tumors. The usual dose for indium In-111 pentetreotide is approximately 5 to 20 times less than for octreotide and is subtherapeutic. The following adverse reactions have been associated with octreotide in 3% to 10% of patients: nausea, injection site pain, diarrhea, abdominal pain/discomfort, loose stools, and vomiting. Hypertension and hyper- and hypoglycemia have also been reported with the use of octreotide.

Read the entire FDA prescribing information for Octreoscan (Indium in -111 Pentetreotide Kit for Intravenous Use)

© Octreoscan Patient Information is supplied by Cerner Multum, Inc. and Octreoscan Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors